Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc.

NASDAQ:CRBP

Overview | Financials
Company Name Corbus Pharmaceuticals Holdings, Inc.
Symbol CRBP
Currency USD
Price 42.48
Market Cap 453,971,016
Dividend Yield 0%
52-week-range 3.033 - 55.41
Industry Biotechnology
Sector Healthcare
CEO Dr. Yuval Cohen Ph.D.
Website https://www.corbuspharma.com

An error occurred while fetching data.

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody

Related Stocks

Oncternal Therapeutics, Inc. logo

Oncternal Therapeutics, Inc.

ONCT

8.18 USD

Biomerica, Inc. logo

Biomerica, Inc.

BMRA

0.448 USD

Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc.

TERN

7.23 USD

Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc.

TPST

2.03 USD

AVROBIO, Inc. logo

AVROBIO, Inc.

AVRO

1.4 USD

Financials

Numbers are in millions USD

Numbers are in millions USD